Customize your JAMA Network experience by selecting one or more topics from the list below.
Practically every day this spring, New York University cardiologist Aakriti Gupta, MD, MS, has received a phone call from friends or relatives in India who have COVID-19. They want to know whether they should start taking statins, which are cheap and available without a prescription in Gupta’s COVID-19–ravaged homeland.
A history of myocardial infarction, congestive heart failure, and hyperlipidemia have all been associated with an increased risk of in-hospital mortality from COVD-19. Observational studies by Gupta and others have suggested that taking statins might not only lower blood cholesterol levels, but also reduce the risk of dying from COVID-19.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Rubin R. Could Statins Do More Than Lower Cholesterol in Patients With COVID-19? JAMA. Published online June 03, 2021. doi:10.1001/jama.2021.8201
Create a personal account or sign in to: